Published in Vaccine Weekly, October 4th, 2006
The announcement coincides with the 23rd International Papillomavirus Congress and Clinical Workshop in Prague, Czech Republic, gathering specialists in the field of HPV diagnostics and therapeutics. Infection with HPV genotypes 16 and 18, amongst others, is strongly associated with the development of cervical cancer, the second most common cause of cancer-related deaths in women worldwide. These genotypes are also present in the recently developed HPV prophylactic vaccines and are all detectable with Innogenetics' HPV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly